Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat

Although the pharmacological effects of fibroblast growth factor 21 (FGF21) are well-documented, uncertainty about its role in regulating excessive energy intake remains. Here, we show that FGF21 improves systemic insulin sensitivity by promoting the healthy expansion of subcutaneous adipose tissue...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nat Commun
Autors principals: Li, Huating, Wu, Guangyu, Fang, Qichen, Zhang, Mingliang, Hui, Xiaoyan, Sheng, Bin, Wu, Liang, Bao, Yuqian, Li, Peng, Xu, Aimin, Jia, Weiping
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5773530/
https://ncbi.nlm.nih.gov/pubmed/29348470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-017-02677-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars